Skip to content

Overlapping Epidemics: TB, HIV and Viral Hepatitis

TB, HIV and Viral Hepatitis By Tracy Swan Disturbing reports of overlapping TB, HIV, and viral hepatitis epidemics emerged at the 2005 International AIDS Society Conference. In the newly independent states of Eastern Europe and Central Asia, HIV incidence continues…

Read more

Taylor-ed Treatment

Brown University Clinician Leads the Way in Providing Competent Care to Coinfected Injectors By Tracy Swan Directly Observed Peg-IFN? A majority of the estimated 4 million hepatitis C virus (HCV) infections in the United States result from injection drug use…

Read more

TAG 2003: The Year at a Glance

by Rob Camp January: starts as new TAG's Antiviral Project Director. Rob and Mark to Houston for ATAC structure meeting to develop stronger national coalition, then to D.C. for Federal AIDS Policy Partnership meeting. Talk of coming assault on Medicaid…

Read more

TAG at Ten: The Year 2002

January: HIV vaccine papers in Nature by Merck's Emilio Emini, Harvard's Dan Barouch. February: First ATAC (AIDS Treatment Activist Conference) teach-in, Seattle (seventy people attend), followed by ATAC/BMS meeting and Retrovirus conference. NIH cancels large phase III canarypox HIV vaccine…

Read more

TAG at Ten: The Year 2001

January: TAG's Gregg Gonsalves becomes GMHC Director of Treatment Policy. Completion of STI Workshop 2000 report. FDA hearing on salvage therapy trial design. Merck meeting on promising DNA/adenovirus HIV vaccine. TAG mobilizes 600 signatures on global letter to Glaxo decrying…

Read more

TAG at Ten: The Year 2000

January: NIH workshops on long term effectiveness research, studies designed to look at "when to start" and switch HAART, and for long-term side effects. TAG hires Yvette Delph as new Antiviral Project Director. Completion of TAG's AIDS Vaccine Research at…

Read more
Back To Top